|
1
|
Mishra BB and Tiwari VK: Natural products:
An evolving role in future drug discovery. Eur J Med Chem.
46:4769–4807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuttan R, Bhanumathy P, Nirmala K and
George MC: Potential anticancer activity of turmeric (Curcuma
longa). Cancer Lett. 29:197–202. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Negi PS, Jayaprakasha GK, Jagan Mohan Rao
L and Sakariah KK: Antibacterial activity of turmeric oil: A
byproduct from curcumin manufacture. J Agric Food Chem.
47:4297–4300. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kunnumakkara AB, Anand P and Aggarwal BB:
Curcumin inhibits proliferation, invasion, angiogenesis and
metastasis of different cancers through interaction with multiple
cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hasima N and Aggarwal BB: Cancer-linked
targets modulated by curcumin. Int J Biochem Mol Biol. 3:328–351.
2012.
|
|
6
|
Kuroyanagi M and Natori S: Some
observation on curcuminoids from Zingiberaceae plants. Yakugaku
Zasshi. 90:1467–1470. 1970.(In Japanese). PubMed/NCBI
|
|
7
|
Sharma RA, Gescher AJ and Steward WP:
Curcumin: The story so far. Eur J Cancer. 41:1955–1968. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuo ML, Huang TS and Lin JK: Curcumin, an
antioxidant and anti-tumor promoter, induces apoptosis in human
leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mehta K, Pantazis P, McQueen T and
Aggarwal BB: Anti-proliferative effect of curcumin
(diferuloylmethane) against human breast tumor cell lines.
Anticancer Drugs. 8:470–481. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen H, Zhang ZS, Zhang YL and Zhou DY:
Curcumin inhibits cell proliferation by interfering with the cell
cycle and inducing apoptosis in colon carcinoma cells. Anticancer
Res. 19:3675–3680. 1999.
|
|
11
|
Motterlini R, Foresti R, Bassi R and Green
CJ: Curcumin, an anti-oxidant and anti-inflammatory agent, induces
heme oxygenase-1 and protects endothelial cells against oxidative
stress. Free Radic Biol Med. 28:1303–1312. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kunnumakkara AB, Guha S, Krishnan S,
Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates
antitumor activity of gemcitabine in an orthotopic model of
pancreatic cancer through suppression of proliferation,
angiogenesis, and inhibition of nuclear factor-kappaB-regulated
gene products. Cancer Res. 67:3853–3861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CC, Chen Y, Hsi YT, Chang CS, Huang
LF, Ho CT, Way TD and Kao JY: Chemical constituents and anticancer
activity of Curcuma zedoaria roscoe essential oil against non-small
cell lung carcinoma cells in vitro and in vivo. J Agric Food Chem.
61:11418–11427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Syu WJ, Shen CC, Don MJ, Ou JC, Lee GH and
Sun CM: Cytotoxicity of curcuminoids and some novel compounds from
Curcuma zedoaria. J Nat Prod. 61:1531–1534. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Pei L, Zhong Z, Guo J, Zhang Q and
Wang Y: Anti-tumor potential of ethanol extract of Curcuma
phaeocaulis Valeton against breast cancer cells. Phytomedicine.
18:1238–1243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Roy SS, Nebie RHC, Zhang Y and Nair
MG: Functional food quality of Curcuma caesia, Curcuma zedoaria and
Curcuma aeruginosa endemic to Northeastern India. Plant Foods Hum
Nutr. 68:72–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanai M, Otsuka Y, Otsuka K, Sato M,
Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S,
et al: A phase I study investigating the safety and
pharmacokinetics of ®) in cancer patients. Cancer
Chemother Pharmacol. 71:1521–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Belcaro G, Hosoi M, Pellegrini L,
Appendino G, Ippolito E, Ricci A, Ledda A, Dugall M, Cesarone MR,
Maione C, et al: A controlled study of a lecithinized delivery
system of curcumin (Meriva®) to alleviate the adverse
effects of cancer treatment. Phytother Res. 28:444–450. 2014.
View Article : Google Scholar
|
|
19
|
Lee H and Lin JY: Antimutagenic activity
of extracts from anti-cancer drugs in Chinese medicine. Mutat Res.
204:229–234. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng CH, Chiu WT, Juan CW, Mau JL, Chen
CC, Peng CC, Lai EY and Chyau CC: Pivotal role of curcuminoids on
the anti-mutagenic activity of Curcuma zedoaria extracts. Drug Chem
Toxicol. 33:64–76. 2010. View Article : Google Scholar
|
|
21
|
Kim KI, Kim JW, Hong BS, Shin DH, Cho HY,
Kim HK and Yang HC: Antitumor, genotoxicity and anticlastogenic
activities of polysaccharide from Curcuma zedoaria. Mol Cells.
10:392–398. 2000.PubMed/NCBI
|
|
22
|
Seo WG, Hwang JC, Kang SK, Jin UH, Suh SJ,
Moon SK and Kim CH: Suppressive effect of Zedoariae rhizoma on
pulmonary metastasis of B16 melanoma cells. J Ethnopharmacol.
101:249–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mau J, Lai EYC, Wang N, Chen C, Chang C
and Chyau C: Composition and antioxidant activity of the essential
oil from Curcuma zedoaria. Food Chem. 82:583–591. 2003. View Article : Google Scholar
|
|
24
|
Lai EY, Chyau CC, Mau JL, Chen CC, Lai YJ,
Shih CF and Lin LL: Antimicrobial activity and cytotoxicity of the
essential oil of Curcuma zedoaria. Am J Chin Med. 32:281–290. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilson B, Abraham G, Manju VS, Mathew M,
Vimala B, Sundaresan S and Nambisan B: Antimicrobial activity of
Curcuma zedoaria and Curcuma malabarica tubers. J Ethnopharmacol.
99:147–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makabe H, Maru N, Kuwabara A, Kamo T and
Hirota M: Anti-inflammatory sesquiterpenes from Curcuma zedoaria.
Nat Prod Res. 20:680–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen W, Lu Y, Gao M, Wu J, Wang A and Shi
R: Anti-angiogenesis effect of essential oil from Curcuma zedoaria
in vitro and in vivo. J Ethnopharmacol. 133:220–226. 2011.
View Article : Google Scholar
|
|
28
|
Zhou L, Zhang K, Li J, Cui X, Wang A,
Huang S, Zheng S, Lu Y and Chen W: Inhibition of vascular
endothelial growth factor-mediated angiogenesis involved in
reproductive toxicity induced by sesquiterpenoids of Curcuma
zedoaria in rats. Reprod Toxicol. 37:62–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Faried A, Faried LS, Nakagawa T, Yamauchi
T, Kitani M, Sasabe H, Nishimura T, Usman N, Kato H, Asao T, et al:
Chemically synthesized sugar-cholestanols possess a preferential
anticancer activity involving promising therapeutic potential
against human esophageal cancer. Cancer Sci. 98:1358–1367. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hashimoto S, Yazawa S, Asao T, Faried A,
Nishimura T, Tsuboi K, Nakagawa T, Yamauchi T, Koyama N, Umehara K,
et al: Novel sugar-cholestanols as anticancer agents against
peritoneal dissemination of tumor cells. Glycoconj J. 25:531–544.
2008. View Article : Google Scholar
|
|
31
|
Faried A, Arifin MZ, Ishiuchi S, Kuwano H
and Yazawa S: Enhanced expression of proapoptotic and autophagic
proteins involved in the cell death of glioblastoma induced by
synthetic glycans. J Neurosurg. 120:1298–1308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishihira T, Hashimoto Y, Katayama M, Mori
S and Kuroki T: Molecular and cellular features of esophageal
cancer cells. J Cancer Res Clin Oncol. 119:441–449. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stoner GD, Kaighn ME, Reddel RR, Resau JH,
Bowman D, Naito Z, Matsukura N, You M, Galati AJ and Harris CC:
Establishment and characterization of SV40 T-antigen immortalized
human esophageal epithelial cells. Cancer Res. 51:365–371.
1991.PubMed/NCBI
|
|
35
|
Franken NAP, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
36
|
Pretlow TG, Delmoro CM, Dilley GG,
Spadafora CG and Pretlow TP: Transplantation of human prostatic
carcinoma into nude mice in Matrigel. Cancer Res. 51:3814–3817.
1991.PubMed/NCBI
|
|
37
|
Gorelik B, Ziv I, Shohat R, Wick M,
Hankins WD, Sidransky D and Agur Z: Efficacy of weekly docetaxel
and bevacizumab in mesenchymal chondrosarcoma: A new theranostic
method combining xenografted biopsies with a mathematical model.
Cancer Res. 68:9033–9040. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mach CM, Mathew L, Mosley SA, Kurzrock R
and Smith JA: Determination of minimum effective dose and optimal
dosing schedule for liposomal curcumin in a xenograft human
pancreatic cancer model. Anticancer Res. 29:1895–1899.
2009.PubMed/NCBI
|
|
39
|
Kim TH, Jiang HH, Youn YS, Park CW, Tak
KK, Lee S, Kim H, Jon S, Chen X and Lee KC: Preparation and
characterization of water-soluble albumin-bound curcumin
nanoparticles with improved antitumor activity. Int J Pharm.
403:285–291. 2011. View Article : Google Scholar
|
|
40
|
Gupta SK, Banerjee AB and Achari B:
Isolation of Ethyl p-methoxycinnamate, the major antifungal
principle of Curcuma zedoaria. Lloydia. 39:218–222. 1976.PubMed/NCBI
|
|
41
|
Carvalho FR, Vassao RC, Nicoletti MA and
Maria DA: Effect of Curcuma zedoaria crude extract against tumor
progression and immunomodulation. J Venom Anim Toxins Incl Trop
Dis. 16:324–341. 2010. View Article : Google Scholar
|
|
42
|
Shin Y and Lee Y: Cytotoxic activity from
Curcuma zedoaria through mitochondrial activation on ovarian cancer
cells. Toxicol Res. 29:257–261. 2013. View Article : Google Scholar
|
|
43
|
Syed Abdul Rahman SN, Abdul Wahab N and
Abd Malek SN: In vitro morphological assessment of apoptosis
induced by anti-proliferative constituents from the rhizomes of
Curcuma zedoaria. Evid Based Complement Alternat Med.
2013:2571082013. View Article : Google Scholar
|
|
44
|
Fraser M, Leung B, Jahani-Asl A, Yan X,
Thompson WE and Tsang BK: Chemoresistance in human ovarian cancer:
The role of apoptotic regulators. Reprod Biol Endocrinol. 1:662003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Blanco-Aparicio C, Renner O, Leal JF and
Carnero A: PTEN, more than the AKT pathway. Carcinogenesis.
28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Georgescu MM: PTEN tumor suppressor
network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177.
2010. View Article : Google Scholar
|
|
47
|
Johnson SM, Gulhati P, Arrieta I, Wang X,
Uchida T, Gao T and Evers BM: Curcumin inhibits proliferation of
colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer
Res. 29:3185–3190. 2009.PubMed/NCBI
|
|
48
|
Weng L, Brown J and Eng C: PTEN induces
apoptosis and cell cycle arrest through
phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
Hum Mol Genet. 10:237–242. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu S, Shen G, Khor TO, Kim JH and Kong AN:
Curcumin inhibits Akt/mammalian target of rapamycin signaling
through protein phosphatase-dependent mechanism. Mol Cancer Ther.
7:2609–2620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Torres J, Rodriguez J, Myers MP, Valiente
M, Graves JD, Tonks NK and Pulido R: Phosphorylation-regulated
cleavage of the tumor suppressor PTEN by caspase-3: Implications
for the control of protein stability and PTEN-protein interactions.
J Biol Chem. 278:30652–30660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bharti AC, Donato N and Aggarwal BB:
Curcumin (diferuloylmethane) inhibits constitutive and
IL-6-inducible STAT3 phosphorylation in human multiple myeloma
cells. J Immunol. 171:3863–3871. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liang G, Liu Z, Wu J, Cai Y and Li X:
Anticancer molecules targeting fibroblast growth factor receptors.
Trends Pharmacol Sci. 33:531–541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Katoh M and Nakagama H: FGF receptors:
Cancer biology and therapeutics. Med Res Rev. 34:280–300. 2014.
View Article : Google Scholar
|
|
54
|
Hu Y, Lu H and Zhang J, Chen J, Chai Z and
Zhang J: Essential role of AKT in tumor cells addicted to FGFR.
Anticancer Drugs. 25:183–188. 2014. View Article : Google Scholar
|
|
55
|
Jubb AM, Oates AJ, Holden S and Koeppen H:
Predicting benefit from anti-angiogenic agents in malignancy. Nat
Rev Cancer. 6:626–635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li A, Varney ML, Valasek J, Godfrey M,
Dave BJ and Singh RK: Autocrine role of interleukin-8 in induction
of endothelial cell proliferation, survival, migration and MMP-2
production and angiogenesis. Angiogenesis. 8:63–71. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Peng JM, Chen YH, Hung SW, Chiu CF, Ho MY,
Lee YJ, Lai TC, Hsiao M, Liang CM and Liang SM: Recombinant viral
protein promotes apoptosis and suppresses invasion of ovarian
adeno-carcinoma cells by targeting α5β1 integrin to down-regulate
Akt and MMP-2. Br J Pharmacol. 165:479–493. 2012. View Article : Google Scholar :
|
